<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Immune checkpoint inhibitors work by reactivating tumor-infiltrating T cells (TILs)	</title>
	<atom:link href="https://biopharmconsortium.com/2014/12/15/immune-checkpoint-inhibitors-work-by-reactivating-tumor-infiltrating-t-cells-tils/feed/" rel="self" type="application/rss+xml" />
	<link>https://biopharmconsortium.com/2014/12/15/immune-checkpoint-inhibitors-work-by-reactivating-tumor-infiltrating-t-cells-tils/#utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=immune-checkpoint-inhibitors-work-by-reactivating-tumor-infiltrating-t-cells-tils</link>
	<description>Consulting for Effective Life R &#38; D and Partnering</description>
	<lastBuildDate>Wed, 12 Sep 2018 21:48:43 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>
</channel>
</rss>
